Parkinson's sufferers in the UK offered new treatment but who will pay the costs?
This article was originally published in Clinica
An electronic implant for treating patients with Parkinson's disease was launched in the UK last week. The Activa device uses tiny electric shocks to block brain signals that cause the disease's characteristic symptoms including tremors, rigidity and unstable posture. It can also treat the disabling side effects of widely-used drug treatments.
You may also be interested in...
Informa Pharma Intelligence has officially launched the seventh Global Generics & Biosimilars Awards, which will take place in October 2020 in Milan, Italy.
Hours before the US FDA confirmed the first drug shortage due to active pharmaceutical ingredient constraints because of the coronavirus situation in China, generics industry leader Mylan came under pressure about the potential impact on its business.
Government advisory committee gives initial nod to what will become Japan’s most expensive single drug, but reimbursement pricing could come in for close scrutiny.